Product Description
Caffeine
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Stimulant
Specifications
| SKU | 02150114-CF |
| Alternate Names | 1,3,7-Trimethylxanthine |
| Base Catalog Number | 150114 |
| Beilstein Registry Number | 17705 |
| Biochemical Physiological Actions | A central nervous system stimulant believed to act through adenosine receptors and monoamine neurotransmitters. It is an adenosine receptor antagonist and adenosine 3′,5′-cyclic monophosphate (cAMP) phosphodiesterase inhibitor. Thus, levels of cAMP increase in cells following treatment with caffeine. It has been reported to affect cellular calcium levels, releasing calcium from intracellular stores. It overrides the cell cycle effects of various chemicals such as protease inhibitors, preventing apoptosis; and it has been shown to inhibit cellular DNA repair mechanisms. |
| Boiling Point | 352° F at 760 mm Hg (sublimes) (NTP, 1992) |
| CAS # | 58-08-2 |
| Density | 1.23 at 64° F (NTP, 1992) |
| EC Number | 200-362-1 |
| Format | Powder |
| Grade | Anhydrous |
| Hazard Statements | H302 |
| Melting Point | 460° F (NTP, 1992) |
| Molecular Formula | C8H10N4O2 |
| Molecular Weight | 194.194 g/mol |
| Personal Protective Equipment | Dust mask , Eyeshields, Faceshields, Gloves |
| pH | pH = 6.9 (1% solution) |
| RTECS Number | EV6475000 |
| Safety Symbol | GHS07 |
| Solubility | 10 to 50 mg/mL at 73° F (NTP, 1992) |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
| Vapor Pressure | 9.0X10-7 mm Hg at 25 deg C /Extrapolated/ |
Documents
Certificate of Analysis (COA)
Safety Data Sheets
English (United States)
Powered by Bioz